Rituximab in the treatment of inflammatory myopathies: a review.

@article{Fasano2017RituximabIT,
  title={Rituximab in the treatment of inflammatory myopathies: a review.},
  author={S Fasano and Patrick A. Gordon and Raouf Hajji and Esthela Loyo and David Alan Isenberg},
  journal={Rheumatology},
  year={2017},
  volume={56 1},
  pages={26-36}
}
Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in refractory myositis did not show a significant difference between the two treatment groups, and doubts have been expressed about its study design. In this review we present an up-to-date overview of the reported experiences of RTX therapy in myositis. A PubMed search was performed to find all the available cases of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 38 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
8 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…